Abstract
Objectives
This study was designed to investigate the distribution of human leukocyte antigen (HLA) classes I and II in a group of Israeli Jewish patients with psoriatic arthritis (PsA) and identify HLA markers related to disease manifestation in PsA.
Patients and methods
Human leukocyte antigens class I and class II (both serologically and from oligotyping) were tested in a group of 50 consecutive patients with PsA, 32 with skin psoriasis (PSO), and 255 healthy persons. Data on age, gender, disease duration, and pattern of rheumatological manifestations—oligoarthritis, polyarthritis, spinal involvement, involvement of distal interphalangeal joints (DIPs), and enthesitis—were registered.
Results
Human leukocyte antigens A3, B13, and B38 alleles were found to be significantly prevalent in PsA compared with PSO patients and healthy controls. HLA-B27 was found in only two out of 50 patients with PsA. Patients with PSO and PsA had significantly increased incidence of HLA-DRB0101 and -DRB0301, while the frequency of HLA-DRB0403 was significantly higher among patients with PsA of Ashkenazi origin. We found a statistically significant association between DIP involvement and the presence of HLA-A26 and -B38, while HLA-DRB0301 was related to spinal involvement.
Conclusions
Psoriatic arthritis in Israeli patients seems to be associated with the presence of HLA-A3, -B13, -B38, -DRB0101, and -DRB0301. HLA-B27 was not a marker of PsA in this cohort of patients, including patients with psoriatic spondyloarthropathy.
Similar content being viewed by others
References
Gladman D, Farewell VT, Nadeau C (1995) Clinical indicators of progression in psoriatic arthritis—multivariate relative risk model. J Rheumatol 22:675–679
Alibert JL (1918) Précis théorique sur les maladies de la peau. Ravier, Paris
Gladman DD, Shuckett R, Russel ML, Thorne JC, Shachter RH (1987) Psoriatic arthritis—an analysis of 220 patients. Q J Med 62:127–141
Espinoza LR (1985) Psoriatic arthritis: further epidemiologic and genetic consideration. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis. Grune and Stratton, Orlando, pp 9–32
Gladmam DD (1985) The role of immunological factors in the pathogenesis and etiology of psoriatic arthritis. In: Gerber LH, Espinoza LR (eds) Psoriatic arthritis. Grune and Stratton, Orlando, pp 33–44
Farber EM, Nall ML (1971) Genetics of psoriasis—twin study. In: Farber EM, Cox AJ (eds) Psoriasis. Proceeding of the International Symposium, Stanford University. Stanford University Press, Stanford, pp 7–13
Moll JMH, Wright V (1973) Familial occurrence of psoriatic arthritis. Ann Rheum Dis 32:181–201
Kammer GM, Soter NA, Gibson DJ et al (1979) Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 9:75–97
Gladman DD, Anhorn KAB, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13:586–592
Roiterg-Tambur CS, Friedman AW, Safirman C, Sherman L, Battat S, Nelken D, Brautbar C (1995) Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens 46:104–110
Schiff B, Mizrahi Y, Orgad S, Yaron M, Gazit E (1982) Association of HLA-Aw31 and HLA-DR1 in patients with adult rheumatoid arthritis. Ann Rheum Dis 4:403–404
Roudier J (2000) Association of MHC and Rheumatoid arthritis with HLA-DR4: the role of repertoire selection. Arthritis Res 2:217–220
Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y (1978) Microdoplet testing for HLA-A, B, C and D antigens. Isr J Clin Pathol 69:103–120
Miller SA, Dykes DD, Polesky HF (1988) A sampling salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Kimura A, Sasazuki T (1991) Eleventh International Histocompatibility Workshop reference protocol for the HLA-DNA typing technique. In: HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop Conference, vol 1. Oxford University Press, New York, pp 397–419, 1991
Eleventh International Histocompatibility Workshop Conference (1991) HLA 1991, vol 1. Oxford University Press, New York
Roux H, Mercier P, Maestracci D et al (1977) Psoriatic arthritis and HLA antigens. J Rheumatology 3 [Suppl 1]:64–65
O'Donnel, O'Loughlin S, Codd MB, Powell FC (1993) HLA typing in Irish psoriatics. Ir Med J 86:65–68
Espinoza LR, Vasey FB, Wilkinson OR, Osterland CH (1978) Association between HLA-B38 and peripheral psoriatic arthritis. Arthritis Rheum 21:72–75
Murray C, Mann DL, Gerber LN, Barth W, Perlmann S, Decker JL, Nigra TP (1980) Histocompatibility alloantigens in psoriasis and psoriatic arthritis. Evidence for the influence of multiple genes in the major histocompatibility complex. J Clin Invest 66:670–675
Braun J, Bollow M, Reminger G, Eggens U, Rudwaleit M, Distler A, Sieper J (1998) Prevalence of spondyloarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41:58–67
Lambert JR, Wright S, Rajah SM, Moll MH (1976) Histocompatibility antigens in psoriatic arthritis. Ann Rheum Dis 35:526–530
Eastmond CJ, Woodrow JC (1977) The HLA system and the arthropathies associated with psoriasis. Ann Rheum Dis 36:112–120
Amstrong RD, Panayi GS, Welsh KI (1983) Histocompatibility antigens in psoriasis, psoriatic arthritis and ankylosing spondylitis. Ann Rheum Dis 42:142–146
Marsal S, Armandans-Gil L, Martinez M, Gallardo D, Ribera A, Lience E (1999) Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford) 38:332–337
Brautbar C, Porat S, Nerken D, Gabriel KR, Cohen T (1977) HLA B27 and ankylosing spondylitis in the Israeli population. J Rheumatol Suppl 3:24–32
Schlosstein L, Terasaki PI, Bluestone R et al (1973) High association of an HLA antigen w27 with ankylosing spondylitis. N Engl J Med 288:704–706
De Vries N, Ronningen KS, Tilanus MG, Bouwns-Rombouts A, Segal R, Egeland T, Thorsby E, van de Putte LB, Brautbar C (1993) HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 41:26–30
Gladman D, Farewell VT, Kopciuk KA, Cook RJ (1998) HLA markers and progression in psoriatic arthritis. J Rheumatol 25:730–733
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elkayam, O., Segal, R. & Caspi, D. Human leukocyte antigen distribution in Israeli patients with psoriatic arthritis. Rheumatol Int 24, 93–97 (2004). https://doi.org/10.1007/s00296-003-0325-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-003-0325-0